Product Information

ESOMEPRAZOLE DR 10 MG PACKET is a generic product labeled by Cipla USA Inc., priced at $5.2259 per EA under NDC 69097052734. Its NADAC has been published 318 times since Jul 22, 2020.

FDA first approved this application on Mar 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the ESOMEPRAZOLE MAGNESIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ESOMEPRAZOLE DR 10 MG PACKET

ESOMEPRAZOLE MAGNESIUM
$5.2259per EA
High Outlier

Strength

10 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097052734

Classification

Generic

Dosage Form

GRANULE, FOR SUSPENSION, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ESOMEPRAZOLE MAGNESIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA211752

FDA Approved

3/23/2020

TE Code

AB

On Market Since

3/24/2020

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for ESOMEPRAZOLE DR 10 MG PACKET has been published 318 times since Jul 22, 2020, and over the history we have for it it has declined 30.9%. The table below summarizes its recorded NADAC range and movement.

Current price$5.2259 per EA
All-time high$7.5669 (Aug 12, 2020)
All-time low$5.2259 (Aug 19, 2026)
52-week high$7.0536
52-week low$5.2259
Median price$6.9129
Average price$6.8221
Largest weekly change+12.1% (Nov 23, 2022)
Weeks tracked318
Tracking sinceJul 22, 2020

Price History

1W

-6.0%

1M

-6.0%

3M

-12.5%

6M

-15.8%

1Y

-22.6%

3Y

-24.4%

5Y

-25.7%

All

-30.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ESOMEPRAZOLE MAGNESIUM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ESOMEPRAZOLE DR 10 MG PACKET?

The current National Average Drug Acquisition Cost (NADAC) for ESOMEPRAZOLE DR 10 MG PACKET, manufactured by Cipla USA Inc., is $5.2259 per EA (NDC 69097052734), effective Aug 19, 2026.

How has the price of ESOMEPRAZOLE DR 10 MG PACKET changed over time?

Over the history we have for it, the NADAC for ESOMEPRAZOLE DR 10 MG PACKET has declined 30.9%. It has been tracked across 318 weekly CMS publications since Jul 22, 2020.

What are the highest and lowest recorded NADAC prices for ESOMEPRAZOLE DR 10 MG PACKET?

Since Jul 22, 2020, the NADAC for ESOMEPRAZOLE DR 10 MG PACKET has ranged from a low of $5.2259 (Aug 19, 2026) to a high of $7.5669 (Aug 12, 2020), with a median of $6.9129 per EA.

Are there cheaper alternatives to ESOMEPRAZOLE DR 10 MG PACKET?

No other NADAC-published product currently shares the active ingredient and strength of ESOMEPRAZOLE DR 10 MG PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ESOMEPRAZOLE DR 10 MG PACKET?

ESOMEPRAZOLE DR 10 MG PACKET (NDC 69097052734) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.